Logotype for DRI Healthcare Trust

DRI Healthcare Trust (DHT-UN) investor relations material

DRI Healthcare Trust Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for DRI Healthcare Trust
Q3 2025 earnings summary6 Nov, 2025

Executive summary

  • Achieved strong Q3 results with double-digit growth in cash receipts, income, and adjusted EBITDA, led by Orserdu, Xolair, and Rydapt, and supported by portfolio diversification and resilient cashflow streams.

  • Completed internalization of investment management, paying a $48 million termination fee and acquiring assets from Persis Capital for $1 million.

  • Completed a synthetic royalty transaction on veligrotug and VRDN-003 for up to $300 million, with $55 million upfront and up to $115 million in milestone payments, expanding exposure to the TED market.

  • Continued execution of NCIB program, repurchasing over 4.5 million units as of September 30, 2025, to enhance unitholder value.

  • EKTERLY approval in July marked a milestone, with royalties beginning on a one-quarter lag and a $22 million payment increasing royalty entitlement.

Financial highlights

  • Q3 2025 total cash receipts: $43.6 million, up 12% year-over-year; total income: $48.7 million, up 17% year-over-year.

  • Adjusted EBITDA: $36.7 million (84% margin), up 17% year-over-year; last twelve months adjusted EBITDA: $155.7 million (82% margin).

  • Adjusted cash earnings per unit: $0.55 for Q3 2025; $2.25 for the last 12 months.

  • Cash and equivalents: $35.6 million; royalties receivable: $52.9 million; credit facility availability: $265.4 million as of September 30, 2025.

  • Declared cash distributions of $0.10 per unit for the quarter.

Outlook and guidance

  • Robust pipeline of over $3 billion in potential opportunities under active evaluation as of September 30, 2025.

  • Guidance for total income CAGR to be updated in Q4, with management expressing confidence in current trajectory.

  • Anticipates first royalty receipts from veligrotug following its first US commercial sale and expects topline results from VRDN-003 phase 3 trials in H1 2026.

  • Expects gradual recovery in Omidria sales into 2026 and continued growth for Vonjo, despite impairment.

  • Focus remains on long-term, sustainable growth and generating strong unitholder returns.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next DRI Healthcare Trust earnings date

Logotype for DRI Healthcare Trust
Q4 20253 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next DRI Healthcare Trust earnings date

Logotype for DRI Healthcare Trust
Q4 20253 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

DRI Healthcare Trust is a specialty finance company focused on investing in healthcare royalties. The company acquires and manages royalty streams and other income-generating assets associated with pharmaceutical and biotechnology products. By partnering with healthcare innovators, DRI Healthcare Trust provides funding while benefiting from long-term revenue derived from global drug sales. The company is headquartered in Toronto, Canada, and its shares are listed on the TSX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage